EPW
IDXX icon

Evolve Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Evolve Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
414
-226
-35% -$127K 0.01% 900
2026
Q1 		$360K Buy
640
+20
+3% +$12.8K 0.02% 710
2025
Q4 		$419K Buy
+620
New +$422K 0.02% 601

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Evolve Private Wealth's IDXX Position: Q2 2026 in Review

Evolve Private Wealth reduced its Idexx Laboratories (IDXX) stake by 35% in Q2 2026, selling an estimated $127K and leaving 414 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #900.

Evolve Private Wealth first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $419K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Evolve Private Wealth held 414 shares of Idexx Laboratories worth $218K as of Q2 2026.
  • Evolve Private Wealth sold 226 Idexx Laboratories shares in Q2 2026, an estimated $127K.
  • Idexx Laboratories made up 0.01% of Evolve Private Wealth's portfolio in Q2 2026, its #900 holding.
  • Evolve Private Wealth first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Idexx Laboratories position peaked at $419K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.